Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia | NEJM
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography | Science Advances
A safe and potent anti-CD19 CAR T cell therapy | Nature Medicine
![Novel Humanized Anti-cd19 Chimeric Antigen Receptor, Its Nucelic Acid Sequence And Its Preparation PURWAR; Rahul ; et al. [INDIAN INSTITUTE OF TECHNOLOGY BOMBAY]](https://uspto.report/patent/app/20210002366/US20210002366A1-20210107-D00001.png "Novel Humanized Anti-cd19 Chimeric Antigen Receptor, Its Nucelic Acid Sequence And Its Preparation PURWAR; Rahul ; et al. [INDIAN INSTITUTE OF TECHNOLOGY BOMBAY]")
Novel Humanized Anti-cd19 Chimeric Antigen Receptor, Its Nucelic Acid Sequence And Its Preparation PURWAR; Rahul ; et al. [INDIAN INSTITUTE OF TECHNOLOGY BOMBAY]
WO2015157252A1 - Treatment of cancer using anti-cd19 chimeric antigen receptor - Google Patents
Cancers | Free Full-Text | Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
Kymriah; INN-tisagenlecleucel
WO2017015427A1 - Methods for improving the efficacy and expansion of immune cells - Google Patents
Frontiers | The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
Molecular structure of chimeric antigen receptor used for CTL019.... | Download Scientific Diagram
Clinical Development
Kymriah, INN-tisagenlecleucel
Clinical Development
Strategies to overcome the side effects of chimeric antigen receptor T cell therapy - Mirzaee Godarzee - 2022 - Annals of the New York Academy of Sciences - Wiley Online Library
The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28 | bioRxiv
Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor | Journal of the American Chemical Society
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts | Journal for ImmunoTherapy of Cancer
Driving Out Chronic Lymphocytic Leukemia With CAR T Cells - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
Clinical use of lentiviral vectors | Leukemia
The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19 - Cytotherapy
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell | Nature Medicine
Frontiers | Development of a Novel Anti-CD19 CAR Containing a Fully Human scFv and Three Costimulatory Domains
Antibodies | Free Full-Text | Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells
